Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2012-07-19Clinical Trial Update: Safety Study of Darinaparsin in Combination With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) to Treat Lymphoma [Phase 1]
A Phase 1 safety study evaluating darinaparsin in combination with CHOP for lymphoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-07-19Clinical Trial Update: A Phase I Trial of ZIO-101 in Hematologic Cancers [Phase 1]
This document reports the completion status of a Phase I trial evaluating ZIO-101 in hematologic cancers sponsored by Alaunos Therapeutics.
-
CLINICAL_TRIALS trial_result · 2012-07-13Clinical Trial Update: Lymphoma and T Helper 2 Cytokines Relationship With Prognostic Markers
A completed clinical trial update examining the relationship between T helper 2 cytokines and prognostic markers in lymphoma.
-
CLINICAL_TRIALS trial_result · 2012-07-09Clinical Trial Update: Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma [Phase 1]
This update summarizes a Phase 1 trial evaluating Velcade (bortezomib) in combination with ICE (ifosfamide, carboplatin, etoposide) for rela…
-
CLINICAL_TRIALS trial_result · 2012-06-28Clinical Trial Update: Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF(Granulocyte-macrophage Colony-stimulating Factor) and Rituximab [Phase 2]
A Phase II lymphoma trial evaluating fludarabine and mitoxantrone followed by GM-CSF and rituximab was terminated. Results from the study ha…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-06-27Clinical Trial Update: Human Leukocyte Antigen (HLA) Class I Haplotype Mismatched Natural Killer Cell Infusions [Phase 1]
Phase 1 clinical trial update on HLA Class I haplotype-mismatched natural killer cell infusions for hematologic cancers, including lymphoma,…
-
CLINICAL_TRIALS withdrawal · 2012-06-20Clinical Trial Update: Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia [Phase 1]
A Phase 1 trial of recombinant human Mannose-Binding Lectin (MBL) in young patients with MBL deficiency and fever with neutropenia was withd…
-
CLINICAL_TRIALS trial_result · 2012-06-19Clinical Trial Update: Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 trial investigating donor stem cell or donor white blood cell infusions in hematologic cancers; the study is terminated with results…
-
CLINICAL_TRIALS trial_result · 2012-06-12Clinical Trial Update: Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic Leukemia [Phase 1, Phase 2]
This clinical trial update reports Phase 1/2 results for a treatment regimen of radiation therapy and chemotherapy followed by peripheral st…
-
CLINICAL_TRIALS research · 2012-06-11Clinical Trial Update: Evolution of Cellular and Viral Resistance in HIV-infected Patients With Lymphoma
This clinical trial update describes research into how both cellular and viral resistance evolves in HIV-infected patients who also have lym…
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation [Phase 2]
Phase 2 trial of peripheral blood lymphocyte therapy using EBV-specific cytotoxic T cells to prevent EBV-related lymphoproliferative disorde…
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer [Phase 1, Phase 2]
This clinical trial update reports the completion of a phase 1/2 study evaluating peripheral stem cell transplantation in patients with brea…
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 trial update evaluating stem cell transplantation as treatment for hematologic cancers. The study includes patients with various hem…
-
CLINICAL_TRIALS trial_result · 2012-06-01Clinical Trial Update: Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 clinical trial update on bone marrow and peripheral stem cell transplantation for patients with hematologic cancers; the study statu…
-
CLINICAL_TRIALS research · 2012-06-01Clinical Trial Update: International Travel Patterns and Risk Behaviour of Breast Cancer, Lymphoma Patients and Bone Marrow Transplant Recipients
A completed observational study assessing international travel patterns and risk behaviors among patients with breast cancer and lymphoma tr…
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders [NA]
Clinical trial update for a study evaluating G-CSF–treated donor bone marrow transplant in hematologic disorders; the trial (NCT00253552) is…
-
CLINICAL_TRIALS trial_result · 2012-05-23Clinical Trial Update: Samsung Medical Center-Lymphoma Cohort Study [NA]
The Samsung Medical Center lymphoma cohort study (NCT00822731) has completed, with lymphoma as the condition and Samsung Medical Center list…
-
CLINICAL_TRIALS trial_result · 2012-05-22Clinical Trial Update: Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies [Phase 2]
Phase 2 clinical trial evaluating natural killer (NK) cell adback after allogeneic stem cell transplant with Campath-IH plus chemoradiation …
-
CLINICAL_TRIALS trial_result · 2012-05-22Clinical Trial Update: Epstein-Barr Virus (EBV)-Specific T Cells as Therapy for Relapsed/Refractory EBV-positive Lymphomas [Phase 1]
A Phase 1 clinical trial tested EBV-specific T cells for relapsed/refractory EBV-positive lymphomas and has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-18Clinical Trial Update: Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer [Phase 1, Phase 2]
This completed Phase 1/2 trial evaluated the combination of liposomal doxorubicin (Doxil) and bortezomib in patients with refractory hematol…
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: Cellular Therapy With Cord Blood Cells [Phase 2]
Phase 2 trial evaluating cord blood cell–based cellular therapy in patients with multiple myeloma, leukemia, or lymphoma. Results were poste…
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: Safety Study Of SNX-5422 To Treat Solid Tumor Cancers And Lymphomas [Phase 1]
A Phase 1 safety study of SNX-5422 for solid tumor malignancies and lymphoid cancers has been completed.
-
CLINICAL_TRIALS trial_result · 2012-05-16Clinical Trial Update: DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas [Phase 1]
Phase 1 clinical trial update indicates the study evaluating DX-8951f in children with advanced solid tumors or lymphomas has completed. The…
-
CLINICAL_TRIALS trial_result · 2012-05-10Clinical Trial Update: A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone [Phase 1, Phase 2]
A Phase 1/2 trial compares mobilisation of peripheral blood progenitor cells using VTP195183 plus G-CSF versus G-CSF alone in patients with …
-
CLINICAL_TRIALS research · 2012-05-01Clinical Trial Update: A Study to Determine the Absorption, Distribution, Metabolism, and Excretion of LBH589 [Phase 1]
A Phase 1 study to determine the absorption, distribution, metabolism, and excretion of LBH589 (panobinostat) in cancer patients with advanc…